These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1756519

  • 21. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
    Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Li LS.
    J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
    [Abstract] [Full Text] [Related]

  • 22. [Blood lipid disorders in the nephrotic syndrome. Physiopathological aspects and therapeutic prospects].
    Campanacci L.
    Minerva Med; 1976 Sep 30; 67(46):2951-60. PubMed ID: 787832
    [No Abstract] [Full Text] [Related]

  • 23. Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity.
    Ellis D, Orchard TJ, Lombardozzi S, Yunis EJ, McCauley J, Agostini R, Diamond JR.
    J Am Soc Nephrol; 1995 Oct 30; 6(4):1170-7. PubMed ID: 8589283
    [Abstract] [Full Text] [Related]

  • 24. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 25. Study of hyperlipidemia in adults with nephrotic syndrome.
    Khanna UB, Nerurkar SV, Almeida AF, Taskar SP, Acharya VN.
    J Postgrad Med; 1985 Jul 26; 31(3):140-5. PubMed ID: 4087215
    [No Abstract] [Full Text] [Related]

  • 26. [Rapidly progressing glomerulonephritis developing against a background of idiopathic nephrotic syndrome].
    Monova D, Belovezhdov N, Minova V, Doĭchinov D.
    Vutr Boles; 1988 Jul 26; 27(6):100-3. PubMed ID: 3247697
    [Abstract] [Full Text] [Related]

  • 27. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency].
    Hyla-Klekot L, Grenda R, Pulcer B.
    Pol Merkur Lekarski; 2008 Dec 26; 25(150):519-22. PubMed ID: 19205386
    [Abstract] [Full Text] [Related]

  • 28. Acquired hyperlipidemia (secondary dyslipoproteinemias).
    Chait A, Brunzell JD.
    Endocrinol Metab Clin North Am; 1990 Jun 26; 19(2):259-78. PubMed ID: 2192873
    [Abstract] [Full Text] [Related]

  • 29. [Nephrotic syndrome (clinico-morphological, immunological and biochemical aspects)].
    Riabov SI, Kozlov VV, Kozhevnikov AD, Rakitianskaia IA, Smirnov AV.
    Ter Arkh; 1988 Jun 26; 60(6):24-8. PubMed ID: 3206362
    [Abstract] [Full Text] [Related]

  • 30. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A, Maíz A, Arteaga A.
    Rev Med Chil; 1998 Mar 26; 126(3):315-21. PubMed ID: 9674303
    [Abstract] [Full Text] [Related]

  • 31. Risks for hyperlipidemia.
    Nestruck AC, Davignon J.
    Cardiol Clin; 1986 Feb 26; 4(1):47-56. PubMed ID: 2871933
    [Abstract] [Full Text] [Related]

  • 32. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN.
    Miner Electrolyte Metab; 1993 Feb 26; 19(3):127-36. PubMed ID: 8232099
    [Abstract] [Full Text] [Related]

  • 33. Hyperlipidemia after organ transplantation.
    Markell MS, Friedman EA.
    Am J Med; 1989 Nov 26; 87(5N):61N-67N. PubMed ID: 2486550
    [Abstract] [Full Text] [Related]

  • 34. Treatment of nephrotic hyperlipidemia with lovastatin.
    Elisaf M, Dardamanis M, Pappas M, Sferopoulos G, Siamopoulos KC.
    Clin Nephrol; 1991 Jul 26; 36(1):50-2. PubMed ID: 1889153
    [No Abstract] [Full Text] [Related]

  • 35. Encephalopathy associated with steroid treated nephrotic syndrome.
    Yu EC, Wong SN, Yeung CY.
    Int J Pediatr Nephrol; 1987 Jul 26; 8(3):135-46. PubMed ID: 3429137
    [Abstract] [Full Text] [Related]

  • 36. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ, Alberta L, Robinson-Bostom L, Bostom A.
    J Am Acad Dermatol; 2005 Nov 26; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [Abstract] [Full Text] [Related]

  • 37. [Nephrotic syndrome. A study of 71 adults].
    Lacress R, Ringoir S, Lameire N, Debroe M.
    Ned Tijdschr Geneeskd; 1971 Sep 25; 115(39):1590-7. PubMed ID: 5121217
    [No Abstract] [Full Text] [Related]

  • 38. [Thyroid function in a child with nephrotic syndrome evolving to renal failure (author's transl)].
    Etling N, Lenoir G, Gehin-Fouque F.
    Arch Fr Pediatr; 1980 Oct 25; 37(8):545-8. PubMed ID: 7447609
    [Abstract] [Full Text] [Related]

  • 39. Treatment of hyperlipidemia in nephrotic syndrome: time for a change?
    Olbricht CJ, Koch KM.
    Nephron; 1992 Oct 25; 62(2):125-9. PubMed ID: 1436302
    [No Abstract] [Full Text] [Related]

  • 40. [Kidney diseases associated with hyperlipidemia and its treatment].
    Aitio ML.
    Duodecim; 1991 Oct 25; 107(16):1315-22. PubMed ID: 1365353
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.